Episode 329: 327. A Cell-free DNA Blood-Based Test for Colorectal Cancer Screening "SHIELD TESTING"
ening, the offer of a blood-based screening test boosted CRC screening by 17.5 percentage points over usual care.That is becauseCRC screening proportions were 17.5 percentage points higher in the bloo...
23 Aug 202412min
Episode 328: 327. Lowering systolic blood pressure to less than 120 mm Hg versus less than 140 mm Hg in patients with high cardiovascular risk
https://pubmed.ncbi.nlm.nih.gov/38945140/The primary outcome was a composite of myocardial infarction, revascularisation, hospitalisation for heart failure, stroke, or death from cardiovascular causes...
2 Aug 20247min
Episode 327: 326. Should We Prescribe Inhaled Insulin? INHALE-3 TRIAL
INHALE-3, a randomized trial, 123patients with type 1 dm that compared the efficacy of an inhaled insulin regimen (Afrezza) plus degludec insulin (Tresiba®) against usual care over 17 weeks The study'...
1 Aug 20247min
Episode 326: 325. The Mysterious NNT
What is a quick and easy way to calculate the NNT
30 Juli 20247min
Episode 325: 324. METHODS MONDAY
What is the different between Absolute and Relative risk reduction
29 Juli 20248min
Episode 324: 323. Is Calcium Bad For You? Calcium Supplementation? Eating Calcium?
https://heart.bmj.com/content/108/12/964https://www.ahajournals.org/doi/10.1161/JAHA.116.003815We have a study that says leads to increase all cause death with calcium supplementsWe have a study that ...
26 Juli 202413min
Episode 323: 322. Follow-up to Adolescence after Early Peanut Introduction for Allergy Prevention
https://evidence.nejm.org/doi/full/10.1056/EVIDoa2300311Peanut consumption, starting in infancy and continuing to age 5 years, provided lasting tolerance to peanut into adolescence irrespective of sub...
24 Juli 20245min
Episode 322: 321. Long-Term Outcomes in Patients with Low Risk Prostate Cancer
https://jamanetwork.com/journals/jama/article-abstract/2819352Conclusions and Relevance In this study, 10 years after diagnosis, 49% of men remained free of progression or treatment, less than 2% dev...
23 Juli 20246min
